Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma

18 May 2022

Abstract excerpt

Programmed cell death (PCD) is a process that regulates the homeostasis of cells in the body, and it plays an important role in tumor immunity. However, the expression profile and clinical characteristics of PCD-related genes remain unclear. In this study, we comprehensively analysed the PCD genes with the tumor microenvironment (TME), drug sensitivity, immunothearapy response, and evaluated their prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35664309
DOI: 10.3389/fgene.2022.900159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung AdenocarcinomaPMID 35664309Read ↗

A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinomaSemantic proximity Read ↗

Expression of Immunogenic Cell Death-Related Genes is Correlated with Immune Microenvironment and Predicts Prognosis in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of Immunogenic cell death-Related Subgroups and Prognosis Model in lung adenocarcinomaSemantic proximity Read ↗

Immunogenic Cell Death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinomaSemantic proximity Read ↗

Development and validation of a pyroptosis -related prognostic model for predicting the prognosis in Lung AdenocarcinomaSemantic proximity Read ↗

Construction of a Novel Damage-Associated Molecular-Pattern-Related Signature to Assess Lung Adenocarcinoma’s Prognosis and Immune LandscapeSemantic proximity Read ↗

An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinomaSemantic proximity Read ↗

Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung CancerSemantic proximity Read ↗

Identification of a novel necroptosis-related lncRNA-based prognostic model and immunological characteristics of Lung AdenocarcinomaSemantic proximity Read ↗

A unique regulated cell death-related classification regarding prognosis and immune landscapes in non-small cell lung cancerSemantic proximity Read ↗

Deciphering biomarker related to 12 programmed cell death to predict prognosis and response to immunotherapy in lung squamous cell carcinomaSemantic proximity Read ↗

Construction and Validation of a Necroptosis-Related Prognostic Model for Lung Adenocarcinoma and The Correlation with Tumor MicroenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.